£300m Cambridge research centre secured

Pfizer is planning to take over Astrazeneca Credit: Dan Kitwood/PA Wire

US drugs giant Pfizer has said it is committed to building a planned research and development hub in Cambridge.

There were doubts over its future because of a possible £63 billion takeover of AstraZeneca, which had initially tabled the plans.

Pfizer has written to the Prime Minister confirming it's intention to see through with the project.

The £300 million base at the Cambridge Biomedial Campus will house about 2,000 researchers.